TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Orthocell Ltd ( (AU:OCC) ) has provided an update.
Orthocell Ltd has issued a supplementary notice for its upcoming Annual General Meeting, scheduled for November 6, 2025. This notice includes additional resolutions, specifically the issuance of short-term performance rights to Mr. Paul Anderson or his nominees. Shareholders are advised to review this supplementary notice alongside the original notice to understand the new resolutions and their implications. The meeting will be held both in-person and online, and shareholders are encouraged to update their proxy votes if they wish to vote on the newly introduced resolutions.
The most recent analyst rating on (AU:OCC) stock is a Hold with a A$1.50 price target. To see the full list of analyst forecasts on Orthocell Ltd stock, see the AU:OCC Stock Forecast page.
More about Orthocell Ltd
Orthocell Ltd operates in the biotechnology industry, focusing on regenerative medicine. The company specializes in developing and commercializing cell therapies and related products aimed at repairing and regenerating soft tissue injuries.
Average Trading Volume: 604,813
Technical Sentiment Signal: Strong Buy
Current Market Cap: A$354.4M
For a thorough assessment of OCC stock, go to TipRanks’ Stock Analysis page.